South San Francisco, CA, United States of America
Annexon, Inc.
Patents = 9
Trademarks = 7
Forward Citations = 29
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
12 inventors (with patents filed for the assignee):
Annexon is a clinical-stage biopharmaceutical company focused on developing novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. The company is leveraging its proprietary anti-C1q antibody platform to address unmet medical needs in a broad spectrum of autoimmune and neurodegenerative diseases.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com